Blood Clots More Likely After Covid-19 Than After Vaccination, Study Finds

Review by Oxford shows risk of rare, serious blood clotting is eight to 10 times greater in people who caught the coronavirus than among people who received any of the first three Western-developed vaccines A study by the University of Oxford found the risk of rare but sometimes-deadly blood clotting is roughly eight to 10…

Read More

Pfizer CEO says third Covid vaccine dose likely needed within 12 months

Pfizer CEO Albert Bourla said people will “likely” need a booster dose of a Covid-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1. Bourla said it’s possible people will need to get vaccinated against the coronavirus annually. “A likely scenario is that there will be likely a…

Read More

Sherry Farrugia Selected by GCMI Board of Directors as Permanent CEO

Sherry Farrugia has been selected by the Global Center for Medical Innovation (GCMI) board of directors as the organization’s permanent CEO, effective April 1, 2021. Farrugia had been serving as interim CEO for GCMI, a Georgia Tech affiliate, since September 2020. “We are so pleased to congratulate Sherry as she joins GCMI in this permanent…

Read More

UGA to establish national NIH-funded center to fight flu

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and…

Read More

Looking back at 15 years of sharing viral genomes to forge ahead

Anniversaries represent an opportunity for revisiting the past to make a leap forward. I’m using a 15-year anniversary of an act of scientific rebellion that changed my life — and affected the lives of many others — to look beyond Covid-19. In March 2006, Europe and other parts of the world were threatened by H5N1, the so-called…

Read More

Thermo Fisher Nears Deal to Buy PPD for More Than $15 Billion

Purchase of drug-testing firm could be finalized this week Thermo Fisher TMO +3.84% Scientific Inc. is nearing a deal to buy pharmaceutical-testing company PPD Inc. PPD +7.14% for more than $15 billion, according to people familiar with the matter, in what would be the latest tie-up among companies that run clinical trials and provide other services for drugmakers. The companies could finalize a…

Read More

Why would a Covid vaccine cause rare blood clots? Researchers have found clues

Aweek after receiving the AstraZeneca Covid-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain, but her levels of platelets, involved in clotting, were low. She was treated with platelet…

Read More

Why Race Matters in Personalized Health Care

Achieving better, more equitable treatments requires looking at multiple factors that affect populations differently, including genetic variations The COVID pandemic, combined with growing support for racial justice, has brought the issue of inequity in health care to the fore. This issue is nothing new—racial and ethnic disparities have been well documented in terms of unequal…

Read More

Pfizer to deliver 10% more doses to U.S. by end of May- CEO

(Reuters) -Pfizer Inc can deliver 10% more doses of its COVID-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two weeks earlier than expected, Chief Executive Officer Albert Bourla said in a tweet on Tuesday. Pfizer had promised to provide the U.S. government with…

Read More